Analytical Data
-
Gene name
KAAG1
- Application
-
Alternative Names
KAAG1; RU2AS
-
Species
Human
-
Source
E. coli
-
Tag
C-6*His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9UBP8
-
Expression Region
M1-K84
-
Protein Length
Full Length
-
Molecular Weight
15.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
KAAG1, a member of the Kallikrein family, has garnered significant attention in recent years due to its potential implications in various biological processes and disease mechanisms. Initially identified as an important player in the regulation of extracellular matrix components, KAAG1's expression is notably altered in conditions such as cancer, inflammation, and cardiovascular diseases. The protein's interaction with serine proteases and its role in proteolytic pathways suggest that it may contribute to tumor progression and metastasis, making it a potential biomarker and therapeutic target. Researchers have focused on the recombinant production of KAAG1 to facilitate detailed studies of its structure, function, and interactions. The development of recombinant KAAG1 protein allows for the elucidation of its biochemical properties and the investigation of its role in cell signaling, providing insights into its potential as a target for drug development. Furthermore, understanding the mechanisms by which KAAG1 influences cellular processes could lead to novel therapeutic strategies for diseases associated with dysregulated expression of this protein. As the scientific community continues to explore the multifaceted roles of KAAG1, its recombinant form serves as a vital tool in deciphering the complexities of its biological functions and therapeutic applications.
